nodes	percent_of_prediction	percent_of_DWPC	metapath
Miglustat—GBA2—renal system—muscle cancer	0.0558	0.092	CbGeAlD
Miglustat—UGCG—renal system—muscle cancer	0.055	0.0907	CbGeAlD
Miglustat—GBA2—cardiac atrium—muscle cancer	0.05	0.0824	CbGeAlD
Miglustat—UGCG—cardiac atrium—muscle cancer	0.0493	0.0813	CbGeAlD
Miglustat—GBA2—tendon—muscle cancer	0.0436	0.0718	CbGeAlD
Miglustat—UGCG—tendon—muscle cancer	0.043	0.0708	CbGeAlD
Miglustat—GBA2—bone marrow—muscle cancer	0.0422	0.0696	CbGeAlD
Miglustat—UGCG—bone marrow—muscle cancer	0.0416	0.0686	CbGeAlD
Miglustat—GBA2—vagina—muscle cancer	0.0404	0.0667	CbGeAlD
Miglustat—UGCG—vagina—muscle cancer	0.0399	0.0657	CbGeAlD
Miglustat—GBA2—head—muscle cancer	0.0373	0.0616	CbGeAlD
Miglustat—UGCG—head—muscle cancer	0.0368	0.0607	CbGeAlD
Miglustat—GBA2—testis—muscle cancer	0.0361	0.0595	CbGeAlD
Miglustat—UGCG—testis—muscle cancer	0.0356	0.0586	CbGeAlD
Miglustat—Cognitive impairment—Methotrexate—muscle cancer	0.0126	0.032	CcSEcCtD
Miglustat—Coagulopathy—Dactinomycin—muscle cancer	0.00973	0.0247	CcSEcCtD
Miglustat—Neuritis—Vincristine—muscle cancer	0.00907	0.023	CcSEcCtD
Miglustat—Polyneuropathy—Doxorubicin—muscle cancer	0.00873	0.0222	CcSEcCtD
Miglustat—Numbness—Vincristine—muscle cancer	0.00817	0.0208	CcSEcCtD
Miglustat—Sensory loss—Vincristine—muscle cancer	0.00781	0.0199	CcSEcCtD
Miglustat—Cognitive disorder—Methotrexate—muscle cancer	0.00759	0.0193	CcSEcCtD
Miglustat—Gait disturbance—Vincristine—muscle cancer	0.00694	0.0176	CcSEcCtD
Miglustat—Tingling sensation—Etoposide—muscle cancer	0.00682	0.0173	CcSEcCtD
Miglustat—Numbness—Etoposide—muscle cancer	0.00661	0.0168	CcSEcCtD
Miglustat—Appetite absent—Methotrexate—muscle cancer	0.0066	0.0168	CcSEcCtD
Miglustat—Neuropathy—Vincristine—muscle cancer	0.00636	0.0162	CcSEcCtD
Miglustat—Sensory loss—Etoposide—muscle cancer	0.00633	0.0161	CcSEcCtD
Miglustat—Neuropathy—Etoposide—muscle cancer	0.00515	0.0131	CcSEcCtD
Miglustat—Pain in extremity—Vincristine—muscle cancer	0.00491	0.0125	CcSEcCtD
Miglustat—Ataxia—Vincristine—muscle cancer	0.00462	0.0117	CcSEcCtD
Miglustat—Muscular weakness—Vincristine—muscle cancer	0.00433	0.011	CcSEcCtD
Miglustat—Weight decreased—Vincristine—muscle cancer	0.00384	0.00976	CcSEcCtD
Miglustat—Neuritis—Doxorubicin—muscle cancer	0.00381	0.00968	CcSEcCtD
Miglustat—Depression—Vincristine—muscle cancer	0.00378	0.0096	CcSEcCtD
Miglustat—Neuropathy peripheral—Vincristine—muscle cancer	0.00371	0.00943	CcSEcCtD
Miglustat—Cramp muscle—Etoposide—muscle cancer	0.00358	0.00911	CcSEcCtD
Miglustat—Chills—Dactinomycin—muscle cancer	0.00341	0.00868	CcSEcCtD
Miglustat—Hypoaesthesia—Vincristine—muscle cancer	0.00338	0.0086	CcSEcCtD
Miglustat—Connective tissue disorder—Vincristine—muscle cancer	0.00334	0.00849	CcSEcCtD
Miglustat—Ill-defined disorder—Dactinomycin—muscle cancer	0.00307	0.00781	CcSEcCtD
Miglustat—Neuropathy peripheral—Etoposide—muscle cancer	0.00301	0.00764	CcSEcCtD
Miglustat—Malaise—Dactinomycin—muscle cancer	0.00299	0.00759	CcSEcCtD
Miglustat—Mental disorder—Vincristine—muscle cancer	0.00298	0.00757	CcSEcCtD
Miglustat—Gait disturbance—Doxorubicin—muscle cancer	0.00291	0.00741	CcSEcCtD
Miglustat—Back pain—Vincristine—muscle cancer	0.00286	0.00727	CcSEcCtD
Miglustat—Discomfort—Dactinomycin—muscle cancer	0.00279	0.00708	CcSEcCtD
Miglustat—Influenza like illness—Doxorubicin—muscle cancer	0.00276	0.00702	CcSEcCtD
Miglustat—Hypoaesthesia—Etoposide—muscle cancer	0.00274	0.00696	CcSEcCtD
Miglustat—Neuropathy—Doxorubicin—muscle cancer	0.00267	0.00679	CcSEcCtD
Miglustat—Vertigo—Vincristine—muscle cancer	0.00266	0.00676	CcSEcCtD
Miglustat—Thrombocytopenia—Dactinomycin—muscle cancer	0.00265	0.00673	CcSEcCtD
Miglustat—Cramps of lower extremities—Doxorubicin—muscle cancer	0.00261	0.00664	CcSEcCtD
Miglustat—Anorexia—Dactinomycin—muscle cancer	0.00258	0.00655	CcSEcCtD
Miglustat—Eye disorder—Etoposide—muscle cancer	0.00257	0.00654	CcSEcCtD
Miglustat—Convulsion—Vincristine—muscle cancer	0.00256	0.00652	CcSEcCtD
Miglustat—Visual disturbance—Methotrexate—muscle cancer	0.00252	0.00639	CcSEcCtD
Miglustat—Chills—Etoposide—muscle cancer	0.00247	0.00628	CcSEcCtD
Miglustat—Nervous system disorder—Vincristine—muscle cancer	0.00237	0.00602	CcSEcCtD
Miglustat—Thrombocytopenia—Vincristine—muscle cancer	0.00236	0.00601	CcSEcCtD
Miglustat—Decreased appetite—Dactinomycin—muscle cancer	0.00235	0.00597	CcSEcCtD
Miglustat—Fatigue—Dactinomycin—muscle cancer	0.00233	0.00592	CcSEcCtD
Miglustat—Back pain—Etoposide—muscle cancer	0.00232	0.00589	CcSEcCtD
Miglustat—Pain—Dactinomycin—muscle cancer	0.00231	0.00587	CcSEcCtD
Miglustat—Muscle spasms—Etoposide—muscle cancer	0.0023	0.00586	CcSEcCtD
Miglustat—Anorexia—Vincristine—muscle cancer	0.0023	0.00585	CcSEcCtD
Miglustat—Ataxia—Methotrexate—muscle cancer	0.00224	0.0057	CcSEcCtD
Miglustat—Feeling abnormal—Dactinomycin—muscle cancer	0.00223	0.00566	CcSEcCtD
Miglustat—Ill-defined disorder—Etoposide—muscle cancer	0.00222	0.00565	CcSEcCtD
Miglustat—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00221	0.00562	CcSEcCtD
Miglustat—Insomnia—Vincristine—muscle cancer	0.00218	0.00555	CcSEcCtD
Miglustat—Paraesthesia—Vincristine—muscle cancer	0.00217	0.00551	CcSEcCtD
Miglustat—Malaise—Etoposide—muscle cancer	0.00216	0.00549	CcSEcCtD
Miglustat—Vertigo—Etoposide—muscle cancer	0.00215	0.00547	CcSEcCtD
Miglustat—Abdominal pain—Dactinomycin—muscle cancer	0.00214	0.00543	CcSEcCtD
Miglustat—Decreased appetite—Vincristine—muscle cancer	0.0021	0.00534	CcSEcCtD
Miglustat—Gastrointestinal disorder—Vincristine—muscle cancer	0.00208	0.0053	CcSEcCtD
Miglustat—Fatigue—Vincristine—muscle cancer	0.00208	0.00529	CcSEcCtD
Miglustat—Convulsion—Etoposide—muscle cancer	0.00208	0.00528	CcSEcCtD
Miglustat—Pain—Vincristine—muscle cancer	0.00207	0.00525	CcSEcCtD
Miglustat—Constipation—Vincristine—muscle cancer	0.00207	0.00525	CcSEcCtD
Miglustat—Pain in extremity—Doxorubicin—muscle cancer	0.00206	0.00525	CcSEcCtD
Miglustat—Migraine—Doxorubicin—muscle cancer	0.00203	0.00516	CcSEcCtD
Miglustat—Discomfort—Etoposide—muscle cancer	0.00202	0.00512	CcSEcCtD
Miglustat—Gastrointestinal pain—Vincristine—muscle cancer	0.00197	0.00502	CcSEcCtD
Miglustat—Ataxia—Doxorubicin—muscle cancer	0.00194	0.00493	CcSEcCtD
Miglustat—Asthenia—Dactinomycin—muscle cancer	0.00194	0.00493	CcSEcCtD
Miglustat—Thrombocytopenia—Etoposide—muscle cancer	0.00192	0.00487	CcSEcCtD
Miglustat—Abdominal pain—Vincristine—muscle cancer	0.00191	0.00485	CcSEcCtD
Miglustat—Abdominal pain upper—Doxorubicin—muscle cancer	0.00189	0.00479	CcSEcCtD
Miglustat—Anorexia—Etoposide—muscle cancer	0.00186	0.00474	CcSEcCtD
Miglustat—Diarrhoea—Dactinomycin—muscle cancer	0.00185	0.0047	CcSEcCtD
Miglustat—Depression—Methotrexate—muscle cancer	0.00183	0.00466	CcSEcCtD
Miglustat—Muscular weakness—Doxorubicin—muscle cancer	0.00182	0.00463	CcSEcCtD
Miglustat—Abdominal distension—Doxorubicin—muscle cancer	0.0018	0.00457	CcSEcCtD
Miglustat—Paraesthesia—Etoposide—muscle cancer	0.00176	0.00446	CcSEcCtD
Miglustat—Asthenia—Vincristine—muscle cancer	0.00173	0.0044	CcSEcCtD
Miglustat—Vomiting—Dactinomycin—muscle cancer	0.00172	0.00437	CcSEcCtD
Miglustat—Decreased appetite—Etoposide—muscle cancer	0.0017	0.00432	CcSEcCtD
Miglustat—Gastrointestinal disorder—Etoposide—muscle cancer	0.00169	0.00429	CcSEcCtD
Miglustat—Fatigue—Etoposide—muscle cancer	0.00169	0.00429	CcSEcCtD
Miglustat—Constipation—Etoposide—muscle cancer	0.00167	0.00425	CcSEcCtD
Miglustat—Pain—Etoposide—muscle cancer	0.00167	0.00425	CcSEcCtD
Miglustat—Haemoglobin—Methotrexate—muscle cancer	0.00166	0.00421	CcSEcCtD
Miglustat—Diarrhoea—Vincristine—muscle cancer	0.00165	0.0042	CcSEcCtD
Miglustat—Haemorrhage—Methotrexate—muscle cancer	0.00165	0.00419	CcSEcCtD
Miglustat—Weight decreased—Doxorubicin—muscle cancer	0.00161	0.0041	CcSEcCtD
Miglustat—Feeling abnormal—Etoposide—muscle cancer	0.00161	0.0041	CcSEcCtD
Miglustat—Nausea—Dactinomycin—muscle cancer	0.00161	0.00408	CcSEcCtD
Miglustat—Gastrointestinal pain—Etoposide—muscle cancer	0.0016	0.00407	CcSEcCtD
Miglustat—Dizziness—Vincristine—muscle cancer	0.0016	0.00406	CcSEcCtD
Miglustat—Visual impairment—Methotrexate—muscle cancer	0.00159	0.00404	CcSEcCtD
Miglustat—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00156	0.00396	CcSEcCtD
Miglustat—Abdominal pain—Etoposide—muscle cancer	0.00155	0.00393	CcSEcCtD
Miglustat—Eye disorder—Methotrexate—muscle cancer	0.00154	0.00392	CcSEcCtD
Miglustat—Vomiting—Vincristine—muscle cancer	0.00154	0.0039	CcSEcCtD
Miglustat—Headache—Vincristine—muscle cancer	0.00151	0.00384	CcSEcCtD
Miglustat—Chills—Methotrexate—muscle cancer	0.00148	0.00376	CcSEcCtD
Miglustat—Mental disorder—Methotrexate—muscle cancer	0.00145	0.00367	CcSEcCtD
Miglustat—Malnutrition—Methotrexate—muscle cancer	0.00144	0.00365	CcSEcCtD
Miglustat—Haemoglobin—Doxorubicin—muscle cancer	0.00144	0.00365	CcSEcCtD
Miglustat—Nausea—Vincristine—muscle cancer	0.00143	0.00365	CcSEcCtD
Miglustat—Haemorrhage—Doxorubicin—muscle cancer	0.00143	0.00363	CcSEcCtD
Miglustat—Hypoaesthesia—Doxorubicin—muscle cancer	0.00142	0.00361	CcSEcCtD
Miglustat—Asthenia—Etoposide—muscle cancer	0.0014	0.00357	CcSEcCtD
Miglustat—Connective tissue disorder—Doxorubicin—muscle cancer	0.0014	0.00357	CcSEcCtD
Miglustat—Back pain—Methotrexate—muscle cancer	0.00139	0.00353	CcSEcCtD
Miglustat—Visual impairment—Doxorubicin—muscle cancer	0.00138	0.0035	CcSEcCtD
Miglustat—Diarrhoea—Etoposide—muscle cancer	0.00134	0.0034	CcSEcCtD
Miglustat—Eye disorder—Doxorubicin—muscle cancer	0.00133	0.00339	CcSEcCtD
Miglustat—Ill-defined disorder—Methotrexate—muscle cancer	0.00133	0.00339	CcSEcCtD
Miglustat—Malaise—Methotrexate—muscle cancer	0.00129	0.00329	CcSEcCtD
Miglustat—Dizziness—Etoposide—muscle cancer	0.00129	0.00329	CcSEcCtD
Miglustat—Vertigo—Methotrexate—muscle cancer	0.00129	0.00328	CcSEcCtD
Miglustat—Chills—Doxorubicin—muscle cancer	0.00128	0.00326	CcSEcCtD
Miglustat—Mental disorder—Doxorubicin—muscle cancer	0.00125	0.00318	CcSEcCtD
Miglustat—Convulsion—Methotrexate—muscle cancer	0.00124	0.00316	CcSEcCtD
Miglustat—Vomiting—Etoposide—muscle cancer	0.00124	0.00316	CcSEcCtD
Miglustat—Malnutrition—Doxorubicin—muscle cancer	0.00124	0.00316	CcSEcCtD
Miglustat—Headache—Etoposide—muscle cancer	0.00123	0.00311	CcSEcCtD
Miglustat—Flatulence—Doxorubicin—muscle cancer	0.00123	0.00311	CcSEcCtD
Miglustat—Discomfort—Methotrexate—muscle cancer	0.00121	0.00307	CcSEcCtD
Miglustat—Nervousness—Doxorubicin—muscle cancer	0.00121	0.00307	CcSEcCtD
Miglustat—Back pain—Doxorubicin—muscle cancer	0.0012	0.00306	CcSEcCtD
Miglustat—Muscle spasms—Doxorubicin—muscle cancer	0.0012	0.00304	CcSEcCtD
Miglustat—Nausea—Etoposide—muscle cancer	0.00116	0.00295	CcSEcCtD
Miglustat—Ill-defined disorder—Doxorubicin—muscle cancer	0.00115	0.00293	CcSEcCtD
Miglustat—Nervous system disorder—Methotrexate—muscle cancer	0.00115	0.00292	CcSEcCtD
Miglustat—Thrombocytopenia—Methotrexate—muscle cancer	0.00115	0.00292	CcSEcCtD
Miglustat—Malaise—Doxorubicin—muscle cancer	0.00112	0.00285	CcSEcCtD
Miglustat—Vertigo—Doxorubicin—muscle cancer	0.00112	0.00284	CcSEcCtD
Miglustat—Anorexia—Methotrexate—muscle cancer	0.00112	0.00284	CcSEcCtD
Miglustat—Convulsion—Doxorubicin—muscle cancer	0.00108	0.00274	CcSEcCtD
Miglustat—Insomnia—Methotrexate—muscle cancer	0.00106	0.00269	CcSEcCtD
Miglustat—Paraesthesia—Methotrexate—muscle cancer	0.00105	0.00267	CcSEcCtD
Miglustat—Discomfort—Doxorubicin—muscle cancer	0.00105	0.00266	CcSEcCtD
Miglustat—Dry mouth—Doxorubicin—muscle cancer	0.00104	0.00263	CcSEcCtD
Miglustat—Dyspepsia—Methotrexate—muscle cancer	0.00103	0.00262	CcSEcCtD
Miglustat—Decreased appetite—Methotrexate—muscle cancer	0.00102	0.00259	CcSEcCtD
Miglustat—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00101	0.00257	CcSEcCtD
Miglustat—Fatigue—Methotrexate—muscle cancer	0.00101	0.00257	CcSEcCtD
Miglustat—Pain—Methotrexate—muscle cancer	0.001	0.00255	CcSEcCtD
Miglustat—Nervous system disorder—Doxorubicin—muscle cancer	0.000995	0.00253	CcSEcCtD
Miglustat—Thrombocytopenia—Doxorubicin—muscle cancer	0.000993	0.00252	CcSEcCtD
Miglustat—Anorexia—Doxorubicin—muscle cancer	0.000967	0.00246	CcSEcCtD
Miglustat—Feeling abnormal—Methotrexate—muscle cancer	0.000966	0.00245	CcSEcCtD
Miglustat—Gastrointestinal pain—Methotrexate—muscle cancer	0.000958	0.00244	CcSEcCtD
Miglustat—Abdominal pain—Methotrexate—muscle cancer	0.000926	0.00235	CcSEcCtD
Miglustat—Insomnia—Doxorubicin—muscle cancer	0.000918	0.00233	CcSEcCtD
Miglustat—Paraesthesia—Doxorubicin—muscle cancer	0.000911	0.00232	CcSEcCtD
Miglustat—Dyspepsia—Doxorubicin—muscle cancer	0.000893	0.00227	CcSEcCtD
Miglustat—Decreased appetite—Doxorubicin—muscle cancer	0.000882	0.00224	CcSEcCtD
Miglustat—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000876	0.00223	CcSEcCtD
Miglustat—Fatigue—Doxorubicin—muscle cancer	0.000875	0.00222	CcSEcCtD
Miglustat—Pain—Doxorubicin—muscle cancer	0.000868	0.00221	CcSEcCtD
Miglustat—Constipation—Doxorubicin—muscle cancer	0.000868	0.00221	CcSEcCtD
Miglustat—Asthenia—Methotrexate—muscle cancer	0.000841	0.00214	CcSEcCtD
Miglustat—Feeling abnormal—Doxorubicin—muscle cancer	0.000836	0.00213	CcSEcCtD
Miglustat—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00083	0.00211	CcSEcCtD
Miglustat—Abdominal pain—Doxorubicin—muscle cancer	0.000802	0.00204	CcSEcCtD
Miglustat—Diarrhoea—Methotrexate—muscle cancer	0.000802	0.00204	CcSEcCtD
Miglustat—Dizziness—Methotrexate—muscle cancer	0.000775	0.00197	CcSEcCtD
Miglustat—Vomiting—Methotrexate—muscle cancer	0.000745	0.00189	CcSEcCtD
Miglustat—Headache—Methotrexate—muscle cancer	0.000734	0.00187	CcSEcCtD
Miglustat—Asthenia—Doxorubicin—muscle cancer	0.000728	0.00185	CcSEcCtD
Miglustat—Nausea—Methotrexate—muscle cancer	0.000696	0.00177	CcSEcCtD
Miglustat—Diarrhoea—Doxorubicin—muscle cancer	0.000694	0.00176	CcSEcCtD
Miglustat—Dizziness—Doxorubicin—muscle cancer	0.000671	0.00171	CcSEcCtD
Miglustat—Vomiting—Doxorubicin—muscle cancer	0.000645	0.00164	CcSEcCtD
Miglustat—Headache—Doxorubicin—muscle cancer	0.000636	0.00162	CcSEcCtD
Miglustat—Nausea—Doxorubicin—muscle cancer	0.000603	0.00153	CcSEcCtD
